Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

11 March 2002

Inflammatory bowel disease in Greece- a hospital-based clinical study of 172 consecutive patients.

Apostolos Giontzis, Panagiotis Davaris, Athanasios J Archimandritis, Pantelis Grigoriadis, Stavros Sougioultziz, Dimitris Kourtesas, Michalis Tzivras

Med Sci Monit 2002; 8(3): CR158-164 :: ID: 420910


BACKGROUND: It has been suggested that inflammatory bowel disease (IBD)has a milder course in Greece than in other Western countries. The purpose of our study was to assessthe clinical picture of IBD in a hospital-based sample of IBD patients, followed from January 1986 toMay 2001. MATERIAL/METHODS: Retrospective study of 172 patients: 130 with UC followed up for 1-360 months(mean 66±57 months) and 42 with CD for 1-240 months (mean: 51.85±63.68 months). RESULTS: 63 UC patients(48%) required hospitalization, 30 (23%) on the first attack; 72 (55%) had left sided colitis and 23(18%) pancolitis; in 6 cases, (5%), surgical intervention was indicated at onset, 4 (3%) were operated.During FU, 15 patients (11.5%) were operated, 4 (3%) as medical emergencies, 3 (2%) due to colon cancer,the others for intractable colitis or long-standing disease; 5 patients (4%) developed toxic dilationof the colon, 3 (2%) developed colon cancer and 4 (4%) extraintestinal malignancies. 7 patients (5%)died; 2 (1.5%) due to the disease and the remainder for other causes. 19 CD patients (45%) had ileocolitisand 14 (33%) colitis; 22 (52%) needed hospitalization on the first attack. In 12 patients (29%) surgicalintervention was required on initial onset or during FU. One patient developed colon cancer (2%). Twomen died (5%) from myocardial infarction. CONCLUSIONS: IBD does not have a milder course in Greece thanin other European populations.

Keywords: Adolescent, Aged, 80 and over, Colitis, Ulcerative, Crohn Disease, Greece, Hospitals, Inflammatory Bowel Diseases, Time Factors

Add Comment 0 Comments

503 2


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

08 Jun 2023 : Clinical Research  

Risk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...

Med Sci Monit In Press; DOI: 10.12659/MSM.940134  

08 Jun 2023 : Clinical Research  

A Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940124  

08 Jun 2023 : Clinical Research  

Burden of COVID-19 on Mental Health of Resident Doctors in Poland

Med Sci Monit In Press; DOI: 10.12659/MSM.940208  

08 Jun 2023 : Clinical Research  

Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...

Med Sci Monit In Press; DOI: 10.12659/MSM.940251  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750